Literature DB >> 4116955

Methotrexate impurities.

D M Valerino.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 4116955     DOI： 10.1016/s0140-6736(72)92435-x

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  4 in total

Review 1.  Clinical pharmacokinetics of methotrexate.

Authors:  D D Shen; D L Azarnoff
Journal:  Clin Pharmacokinet       Date:  1978 Jan-Feb       Impact factor: 6.447

2.  Acute fever and delayed leukoencephalopathy following low dose intraventricular methotrexate.

Authors:  W Boogerd; J J vd Sande; D Moffie
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-10       Impact factor: 10.154

3.  Calcified cerebral necrosis following ALL therapy.

Authors:  K M Müller; R Menne; K D Bachmann; H Gröbe
Journal:  J Cancer Res Clin Oncol       Date:  1981       Impact factor: 4.553

4.  Acute reversible neurological deficit following intrathecal chemotherapy.

Authors:  H Dunkelman; H M Earl; C Twelves
Journal:  Cancer Chemother Pharmacol       Date:  1991       Impact factor: 3.333
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.